CELU Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Celularity Insider Trading History Chart

Celularity Share Price & Price History

^$1.60

▼ -0.07 (-4.19%)

As of 12/12/2025 05:00 PM ET

Days: 30 | 90 | 365

Celularity Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2024	Kok Thay Lim	Major Shareholder	Buy	2,141,098	$2.50	$5,352,745.00	5,147,376
10/5/2023	Robert J Hariri	CEO	Buy	935,758	$1.60	$1,497,212.80	2,857,043
9/29/2023	Robert J Hariri	CEO	Buy	906,453	$1.70	$1,540,970.10	1,921,284

SEC Filings (Institutional Ownership Changes) for Celularity (NASDAQ:CELU)

19.02% of Celularity stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Celularity Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2025	Yorkville Advisors Global LP	100,000	$0.21M	0.0%	N/A	0.375%
11/12/2025	Perennial Investment Advisors LLC	13,629	$28K	0.0%	N/A	0.051%
11/7/2025	Vanguard Group Inc.	676,650	$1.40M	0.0%	+35.3%	2.535%
10/23/2025	HB Wealth Management LLC	40,415	$84K	0.0%	N/A	0.151%
8/15/2025	Bank of America Corp DE	37,300	$73K	0.0%	+1,538.1%	0.156%
8/12/2025	XTX Topco Ltd	21,452	$42K	0.0%	+106.4%	0.090%
7/23/2025	Valmark Advisers Inc.	49,983	$98K	0.0%	N/A	0.209%
5/21/2025	Acadian Asset Management LLC	20,158	$34K	0.0%	N/A	0.085%
2/17/2025	Two Sigma Investments LP	44,914	$93K	0.0%	N/A	0.189%
2/12/2025	Biltmore Family Office LLC	35,000	$73K	0.0%	N/A	0.147%
2/12/2025	C V Starr & Co. Inc.	764,069	$1.59M	1.2%	N/A	3.209%
2/12/2025	Geode Capital Management LLC	131,510	$0.27M	0.0%	-4.3%	0.552%
2/5/2025	Keynote Financial Services LLC	25,023	$52K	0.0%	+90.1%	0.114%
11/16/2024	Geode Capital Management LLC	137,474	$0.41M	0.0%	-2.9%	0.625%
8/9/2024	Renaissance Technologies LLC	25,498	$80K	0.0%	-14.3%	0.132%
6/13/2024	Keynote Financial Services LLC	15,566	$81K	0.1%	N/A	0.080%
5/10/2024	Vanguard Group Inc.	384,918	$2.01M	0.0%	-89.7%	1.986%
4/30/2024	HB Wealth Management LLC	24,000	$0.13M	0.0%	-60.0%	0.124%
11/15/2023	Armistice Capital LLC	4,700,000	$1.04M	0.0%	+1.2%	2.461%
11/9/2023	IPG Investment Advisors LLC	171,695	$38K	0.0%	+97.9%	0.090%
10/13/2023	HB Wealth Management LLC	187,500	$42K	0.0%	+36.4%	0.098%
7/13/2023	HB Wealth Management LLC	137,500	$73K	0.0%	+26.3%	0.076%
5/12/2023	IPG Investment Advisors LLC	86,767	$54K	0.0%	+85.5%	0.053%
5/9/2023	Gladius Capital Management LP	41,835	$26K	0.0%	N/A	0.025%
5/9/2023	Y Intercept Hong Kong Ltd	41,537	$26K	0.0%	N/A	0.025%
4/13/2023	HB Wealth Management LLC	108,882	$67K	0.0%	+26.0%	0.066%
4/13/2023	Allspring Global Investments Holdings LLC	45,177	$28K	0.0%	+212.8%	0.027%
2/13/2023	The Manufacturers Life Insurance Company	29,150	$38K	0.0%	N/A	0.020%
2/8/2023	Swiss National Bank	120,236	$0.16M	0.0%	+85.4%	0.083%
2/7/2023	Commonwealth Equity Services LLC	35,220	$45K	0.0%	-28.1%	0.024%
2/7/2023	Biltmore Family Office LLC	113,500	$0.15M	0.0%	+103.4%	0.078%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	20,333	$26K	0.0%	N/A	0.014%
1/20/2023	HB Wealth Management LLC	86,402	$0.11M	0.0%	+40.8%	0.060%
11/15/2022	Palantir Technologies Inc.	118,727	$0.27M	0.5%	-86.0%	0.086%
11/14/2022	Tudor Investment Corp Et Al	54,792	$0.13M	0.0%	-22.6%	0.040%
11/14/2022	Point72 Hong Kong Ltd	15,234	$35K	0.0%	+264.0%	0.011%
11/14/2022	IPG Investment Advisors LLC	46,767	$0.11M	0.0%	+32.1%	0.034%
11/9/2022	B. Riley Financial Inc.	376,821	$0.87M	0.2%	N/A	0.272%
11/8/2022	New York State Common Retirement Fund	43,300	$100K	0.0%	+53.0%	0.031%
11/7/2022	Virtu Financial LLC	12,849	$30K	0.0%	N/A	0.009%
11/7/2022	Capital Advisory Group Advisory Services LLC	17,300	$40K	0.0%	+37.8%	0.013%
11/3/2022	Global Retirement Partners LLC	12,900	$30K	0.0%	+158.0%	0.009%
10/31/2022	SG Americas Securities LLC	11,310	$26K	0.0%	N/A	0.008%
10/26/2022	Allspring Global Investments Holdings LLC	14,759	$34K	0.0%	N/A	0.011%
10/24/2022	McKinley Carter Wealth Services Inc.	23,438	$54K	0.0%	N/A	0.017%
8/16/2022	Palantir Technologies Inc.	848,957	$2.89M	3.0%	-46.2%	0.614%
8/9/2022	Swiss National Bank	64,836	$0.22M	0.0%	N/A	0.047%
8/8/2022	IPG Investment Advisors LLC	35,397	$0.12M	0.0%	+182.3%	0.026%
8/4/2022	Biltmore Family Office LLC	21,500	$73K	0.0%	N/A	0.016%
7/19/2022	Commonwealth Equity Services LLC	49,805	$0.17M	0.0%	N/A	0.036%
7/15/2022	HB Wealth Management LLC	61,382	$0.21M	0.0%	+99.6%	0.044%
7/13/2022	Private Advisor Group LLC	11,080	$38K	0.0%	N/A	0.008%
5/11/2022	Starr International Co. Inc.	15,281,389	$133.10M	89.1%	+76.9%	11.096%
5/11/2022	C V Starr & Co. Inc.	7,640,693	$66.55M	93.2%	+76.9%	5.548%
5/9/2022	Qube Research & Technologies Ltd	27,321	$0.24M	0.0%	N/A	0.020%
4/29/2022	Capital Advisory Group Advisory Services LLC	11,000	$96K	0.0%	N/A	0.008%
4/26/2022	Sciencast Management LP	20,058	$0.18M	0.0%	N/A	0.015%
4/25/2022	HighMark Wealth Management LLC	4,417	$29K	0.0%	N/A	0.003%
2/14/2022	LMR Partners LLP	33,736	$0.17M	0.0%	N/A	0.027%
2/9/2022	Lazard Asset Management LLC	9,411	$48K	0.0%	N/A	0.008%
1/27/2022	C V Starr & Co. Inc.	4,320,347	$22.12M	81.6%	N/A	3.499%
1/27/2022	Starr International Co. Inc.	8,640,695	$44.24M	73.9%	N/A	6.999%
11/16/2021	Verition Fund Management LLC	50,000	$0.35M	0.0%	N/A	0.040%
11/15/2021	Marshall Wace LLP	12,291	$87K	0.0%	N/A	0.010%
11/15/2021	Penserra Capital Management LLC	12,566	$88K	0.0%	N/A	0.010%
11/15/2021	Lombard Odier Asset Management USA Corp	40,000	$0.28M	0.0%	N/A	0.032%
11/12/2021	Caption Management LLC	20,000	$0.14M	0.0%	N/A	0.016%
11/9/2021	BlackRock Inc.	25,305	$0.18M	0.0%	N/A	0.020%

Data available starting January 2016

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. It is also developing CYCART-201 for the treatment of NHL and MCL, and human epidermal growth factor receptor 2 positive cancers; CYNK-301, a next generation chimeric antigen receptor-natural killer (CAR-NK) for treating relapse refractory AML; CYNK-302, a CAR-NK to treat non-small cell lung cancer; and pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. It also produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. The company was founded in 1998 and is based in Florham Park, New Jersey.

Today's Range

Now: $1.60

$1.58

$1.73

50 Day Range

MA: $1.90

$1.52

$2.27

52 Week Range

Now: $1.60

$1.00

$4.35

Volume

95,316 shs

Average Volume

57,990 shs

Market Capitalization

$45.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Who are the company insiders with the largest holdings of Celularity?: Celularity's top insider shareholders include:
Kok Thay Lim (Major Shareholder)
Learn More about top insider investors at Celularity.
Who are the major institutional investors of Celularity?: Celularity's top institutional shareholders include:
Vanguard Group Inc. — 2.54%
Yorkville Advisors Global LP — 0.37%
HB Wealth Management LLC — 0.15%
Susquehanna International Group LLP — 0.00%
Citadel Advisors LLC — 0.00%
Perennial Investment Advisors LLC — 0.05%
Learn More about top institutional investors of Celularity stock.
Which major investors are selling Celularity stock?: During the previous quarter, CELU stock was sold by these institutional investors:
Group One Trading LLC
Which major investors are buying Celularity stock?: Within the previous quarter, CELU stock was purchased by institutional investors including:
Vanguard Group Inc.
Yorkville Advisors Global LP
HB Wealth Management LLC
Susquehanna International Group LLP
Citadel Advisors LLC
Perennial Investment Advisors LLC